An oncolytic virus–T cell chimera for cancer immunotherapy
Most Cited Paper
in Virus-based gene therapy research
18 Months Post-Publication
Class of 2026
“An oncolytic virus–T cell chimera for cancer immunotherapy”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026/
Topics
Oncolytic virus · T cell chimera · Cancer immunotherapy · viral vector engineering · Adoptive cell therapy · tumor-infiltrating lymphocytes · Oncolytic virotherapy · immune cell delivery · combination immunotherapy · engineered T cells · Therapeutic viruses · tumor microenvironment · Therapeutic viruses · Adoptive cell therapy
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Virus-based gene therapy research Papers, Class of 2026. https://pri.pepkio.com/top-papers/virus-based-gene-therapy-research/2026. Accessed 2026-07-20. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459